Li Dean Y

Li Dean Y is listed in filings as Director at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2026, including 3 public disclosures. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX) and Merck & Co., Inc. (MRK). The current snapshot covers public activity from May 7, 2026 to Jul 2, 2026. Reported amounts are shown as $6.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.